Tissue inhibitor metalloproteinase-1 and clinical outcomes after acute ischemic stroke
Abstract
Objective
To prospectively investigate the relationships between serum tissue inhibitor metalloproteinase-1 (TIMP-1) and clinical outcomes in patients with acute ischemic stroke.Methods
We derived data from the China Antihypertensive Trial in Acute Ischemic Stroke. Baseline serum TIMP-1 concentrations were measured in 3,342 participants. The primary outcome was the combination of death and major disability (modified Rankin...Paper Details
Title
Tissue inhibitor metalloproteinase-1 and clinical outcomes after acute ischemic stroke
Published Date
Oct 29, 2019
Journal
Volume
93
Issue
18
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History